Arterially enhancing liver lesions: Significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging

Journal of Computer Assisted Tomography

Volumn 31, Issue 1, 2007, Pages 116-124

  Brancatelli, Giuseppe ^a,b,c,f   Federle, Michael P ^c   Baron, Richard L ^d   Lagalla, Roberto ^b   Midiri, Massimo ^b   Vilgrain, Valérie ^e  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e BEAUJON HOSPITAL   (France)

^f NONE   (Italy)

Author keywords

Liver; Magnetic resonance; Neoplasms

Indexed keywords

MAGNETISM; RESONANCE; TUMORS;

BENIGN LESION; HEPATIC LESIONS; LIVER LESIONS; MORPHOLOGICAL CHARACTERISTIC; NEOPLASM; PSEUDOLESIONS;

MAGNETIC RESONANCE IMAGING;

ARTERIOVENOUS SHUNT; BILE DUCT CARCINOMA; CAPILLARY HEMANGIOMA; CAVERNOUS HEMANGIOMA; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; FATTY LIVER; HEPATIC VEIN; HUMAN; LIVER BLOOD VESSEL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER INJURY; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PELIOSIS HEPATIS; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SPLEEN INJURY; TELANGIECTASIA; VASCULAR DISEASE;

EID: 33846659735     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000232474.30033.06     Document Type: Review

References (31)

1. Valls C, Andia E, Sanchez A, et al. Hyperenhancing focal liver lesions: differential diagnosis with helical CT. AJR. 1999;173:605-611.
2. Oliver JH 3rd, Baron RL, Federle MP, et al. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR. 1996;167:71-77.
3. Brancatelli G, Baron RL, Peterson MS, et al. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR. 2003;180:1007-1014.
4. Iannaccone R, Laghi A, Catalano C, et al. Focal liver lesions in the cirrhotic patient: multislice spiral CT evaluation. Radiol Med. 2004;107:304-314.
5. Hanafusa K, Ohashi I, Gomi N, et al. Differential diagnosis of early homogeneously enhancing hepatocellular carcinoma and hemangioma by two-phase CT. J Comput Assist Tomogr. 1997;21:361-368.
6. Leconte I, Van Beers BE, Lacrosse M, et al. Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr. 2000;24:61-66.
7. Attal P, Vilgrain V, Brancatelli G, et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology. 2003;228:465-472.
8. Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004;126:1323-1329.
9. Soyer P, Lacheheb D, Caudron C, et al. MRI of adenomatous hyperplastic nodules of the liver in Budd-Chiari syndrome. J Comput Assist Tomogr. 1993;17:86-89.
10. Vilgrain V, Lewin M, Vons C, et al. Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology. 1999;210:443-450.
11. Zeitoun D, Brancatelli G, Colombat M, et al. Congenital hepatic fibrosis: CT findings in 18 adults. Radiology. 2004;231:109-116.
12. Kim T, Murakami T, Sugihara E, et al. Hepatic nodular lesions associated with abnormal development of the portal vein. AJR. 2004;183:1333-1338.
13. Brancatelli G, Federle MP, Grazioli L, et al. Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics. 2002;22:847-862.
14. Brancatelli G, Federle MP, Grazioli L, et al. Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR. 2002;178:877-883.
15. Ito K, Mitchell DG, Gabata T, et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology. 1999;212:235-240.
16. Krinsky GA, Lee VS, Nguyen MT, et al. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology. 2001;218:47-53.
17. Memeo M, Stabile Ianora AA, Scardapane A, et al. Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs. Radiol Med. 2005;109:125-138.
18. Ravard G, Soyer P, Boudiaf M, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr. 2004;28:488-495.
19. Ohtomo K, Baron RL, Dodd GD 3rd, et al. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology. 1993;189:871-874.
20. Ahn IO, de Lange EE. Early hyperenhancement of confluent hepatic fibrosis on dynamic MR imaging. AJR. 1998;171:901-902.
21. Itai Y, Saida Y. Pitfalls in liver imaging. Eur Radiol. 2002;12:1162-1174.
22. Arita T, Matsunaga N, Honma Y, et al. Focally spared area of fatty liver caused by arterioportal shunt. J Comput Assist Tomogr. 1996;20:360-362.
23. Earls JP, Krinsky GA. Abdominal and pelvic applications of opposed-phase MR imaging. AJR. 1997;169:1071-1077.
24. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology. 2005;237:938-944.
25. Shimizu A, Ito K, Koike S, et al. Cirrhosis or chronic hepatitis: evaluation of small (< or = 2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology. 2003;226:550-555.
26. Itai Y, Hachiya J, Makita K, et al. Transient hepatic attenuation differences on dynamic computed tomography. J Comput Assist Tomogr. 1987;11:461-465.
27. Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis hepatis: spectrum of imaging findings. AJR. 2006;187:W43-52.
28. Pekkafali Z, Karsli AF, Silit E, et al. Intrahepatic splenosis: a case report. Eur Radiol. 2002;12suppl 3:S62-S65.
29. Yoshida Y, Imai Y, Murakami T, et al. Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging. 1999;24:66-68.
30. Lacomis JM, Baron RL, Oliver JH 3rd, et al. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology. 1997;203:98-104.
31. Ward J, Robinson PJ. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol. 2002;12:2258-2272.